What is the current annual EBITDA of RGEN?

As of today, RGEN annual EBITDA is $138.32M

What is 1-year change in RGEN annual EBITDA?

RGEN annual EBITDA is up +26.66% year-over-year

What is 3-year change in RGEN annual EBITDA?

RGEN annual EBITDA is down -45.32% over the past 3 years

How far is RGEN annual EBITDA from its all-time high?

RGEN annual EBITDA is currently -45.32% below its historical high of $252.95M set on December 31, 2022

How does RGEN annual EBITDA rank versus sector peers?

RGEN annual EBITDA is higher than 85.30% of companies in Healthcare sector

When is RGEN next annual earnings release?

The next annual earnings release for RGEN is on February 23, 2027

What is the current quarterly EBITDA of RGEN?

As of today, RGEN quarterly EBITDA is $32.08M

What is RGEN quarterly EBITDA most recent change?

RGEN quarterly EBITDA was down -27.31% on September 30, 2026

What is 1-year change in RGEN quarterly EBITDA?

RGEN quarterly EBITDA is down -34.64% year-over-year

How far is RGEN quarterly EBITDA from its all-time high?

RGEN quarterly EBITDA is currently -60.87% below its historical high of $81.98M set on June 30, 2022

How does RGEN quarterly EBITDA rank versus sector peers?

RGEN quarterly EBITDA is higher than 81.56% of companies in Healthcare sector

When is RGEN next earnings release?

The next earnings release for RGEN is on February 23, 2027

What is the current TTM EBITDA of RGEN?

As of today, RGEN TTM EBITDA is $161.90M

What is RGEN TTM EBITDA most recent change?

RGEN TTM EBITDA was down -9.50% on September 30, 2026

What is 1-year change in RGEN TTM EBITDA?

RGEN TTM EBITDA is down -5.27% year-over-year

How far is RGEN TTM EBITDA from its all-time high?

RGEN TTM EBITDA is currently -45.13% below its historical high of $295.06M set on September 30, 2022

How does RGEN TTM EBITDA rank versus sector peers?

RGEN TTM EBITDA is higher than 84.25% of companies in Healthcare sector

When is RGEN next earnings release?

The next earnings release for RGEN is on February 23, 2027

RGEN EBITDA History & Chart Since 1984

Annual EBITDA

$138.32M$29.12M+26.66%

December 31, 2025

Summary

Current Value: As of today, RGEN annual EBITDA is $138.32M, up +26.66% on December 31, 2025
Historical Performance: RGEN annual EBITDA is down -45.32% over the past 3 years, up +27.66% over the past 5 years
All-Time High Comparison: RGEN annual EBITDA is currently -45.32% below its historical high of $252.95M set on December 31, 2022
3-Year Low Comparison: RGEN annual EBITDA is +26.66% above its 3-year low of $109.21M reached on December 31, 2024
Sector Comparison: RGEN annual EBITDA is higher than 85.30% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

RGEN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$138.32M	+26.7%	-45.3%	+27.7%	+7199.0%
Quarterly EBITDA	Sep 30, 26	$32.08M	-34.6%	+65.8%	-45.8%	+1812.9%
TTM EBITDA	Sep 30, 26	$161.90M	-5.3%	+16.0%	-17.1%	+9552.9%
Price	Oct 30, 26	$176.94	+22.4%	+55.0%	-39.1%	+5119.5%
PE Ratio	Oct 30, 26	-	–	–	–	–
Annual Revenue	Dec 31, 25	$738.26M	+16.4%	-7.9%	+101.6%	+2261.1%
Annual EPS	Dec 31, 25	$0.86	+289.5%	-73.3%	-22.3%	+1334.9%
	Dec 31, 25	$59.58M	+163.1%	-69.6%	-26.7%	+10000.0%
Annual Net Income	Dec 31, 25	$48.89M	+291.6%	-73.7%	-18.4%	+2373.9%

EBITDA Highs

RGEN Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$252.95M	N/A	-45.3%
5Y	$252.95M	Dec 31, 22	-45.3%
All	$252.95M	Dec 31, 22	-45.3%

EBITDA Lows

RGEN Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$109.21M	Dec 31, 24	+26.7%
5Y	$108.36M	N/A	+27.7%
All	-$19.10M	Mar 31, 95	+824.2%

EBITDA History

Year	Value	Change
2025	$138.32M	+26.7%
2024	$109.21M	-19.4%
2023	$135.45M	-46.5%
2022	$252.95M	+9.2%
2021	$231.69M	+113.8%
2020	$108.36M	+77.8%
2019	$60.95M	+36.5%
2018	$44.67M	+79.5%
2017	$24.89M	-7.0%
2016	$26.76M	+19.3%
2015	$22.44M	+27.5%
2014	$17.60M	-32.5%
2013	$26.08M	+82.7%
2012	$14.28M	+653.4%
2011	$1.90M	+143.2%
2010	-$4.39M	-188.5%
2009	$4.96M	+243.5%
2008	-$3.45M	-168.5%
2007	-$1.29M	-56.6%
2006	-$821.50K	+75.9%
2005	-$3.41M	+48.7%

Year	Value	Change
2004	-$6.64M	-54.7%
2003	-$4.29M	+19.3%
2002	-$5.32M	+24.6%
2001	-$7.06M	-99.0%
2000	-$3.55M	-144.0%
1999	-$1.45M	-87.4%
1998	-$775.30K	-11.0%
1997	-$698.60K	+92.8%
1996	-$9.72M	+49.1%
1995	-$19.10M	-4.7%
1994	-$18.24M	-90.0%
1993	-$9.60M	+17.9%
1992	-$11.70M	-58.1%
1991	-$7.40M	-335.3%
1990	-$1.70M	+39.3%
1989	-$2.80M	-366.7%
1988	-$600.00K	+86.0%
1987	-$4.30M	-115.0%
1986	-$2.00M	-17.6%
1985	-$1.70M	-

FAQ

What is the current annual EBITDA of RGEN?: As of today, RGEN annual EBITDA is $138.32M
What is 1-year change in RGEN annual EBITDA?: RGEN annual EBITDA is up +26.66% year-over-year
What is 3-year change in RGEN annual EBITDA?: RGEN annual EBITDA is down -45.32% over the past 3 years
How far is RGEN annual EBITDA from its all-time high?: RGEN annual EBITDA is currently -45.32% below its historical high of $252.95M set on December 31, 2022
How does RGEN annual EBITDA rank versus sector peers?: RGEN annual EBITDA is higher than 85.30% of companies in Healthcare sector
When is RGEN next annual earnings release?: The next annual earnings release for RGEN is on February 23, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$32.08M$12.06M-27.31%

September 30, 2026

Summary

Current Value: As of today, RGEN quarterly EBITDA is $32.08M, down -27.31% on September 30, 2026
Historical Performance: RGEN quarterly EBITDA is down -34.64% year-over-year, up +65.81% over the past 3 years
All-Time High Comparison: RGEN quarterly EBITDA is currently -60.87% below its historical high of $81.98M set on June 30, 2022
3-Year Low Comparison: RGEN quarterly EBITDA is +86.80% above its 3-year low of $17.18M reached on September 30, 2024
Sector Comparison: RGEN quarterly EBITDA is higher than 81.56% of companies in Healthcare sector

Performance

RGEN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$32.08M	-27.3%	-34.6%	+65.8%	-45.8%
Annual EBITDA	Dec 31, 25	$138.32M	–	+26.7%	-45.3%	+27.7%
TTM EBITDA	Sep 30, 26	$161.90M	-9.5%	-5.3%	+16.0%	-17.1%
Price	Oct 30, 26	$176.94	+23.2%	+22.4%	+55.0%	-39.1%
PE Ratio	Oct 30, 26	-	–	–	–	–
Quarterly Revenue	Sep 30, 26	$209.31M	+2.5%	+10.9%	+48.3%	+17.4%
Quarterly EPS	Sep 30, 26	-$0.68	-868.7%	-357.6%	-328.6%	-216.4%
	Sep 30, 26	$12.96M	-33.9%	-12.3%	+409.4%	-73.6%
Quarterly Net Income	Sep 30, 26	-$38.43M	-867.4%	-357.7%	-327.1%	-214.7%

Quarterly EBITDA Highs

RGEN Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$49.09M	N/A	-34.6%
3Y	$49.09M	Sep 30, 25	-34.6%
5Y	$81.98M	Jun 30, 22	-60.9%
All	$81.98M	Jun 30, 22	-60.9%

Quarterly EBITDA Lows

RGEN Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$32.08M	Sep 30, 26	at low
3Y	$17.18M	Sep 30, 24	+86.8%
5Y	$17.18M	Sep 30, 24	+86.8%
All	-$10.90M	Mar 31, 90	+394.3%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$32.08M	-27.3%
Jun 2026	$44.14M	+3.8%
Mar 2026	$42.53M	-1.4%
Dec 2025	$43.15M	-12.1%
Sep 2025	$49.09M	+13.7%
Jun 2025	$43.19M	+3.5%
Mar 2025	$41.74M	+13.1%
Dec 2024	$36.90M	+114.8%
Sep 2024	$17.18M	-40.2%
Jun 2024	$28.74M	+2.4%
Mar 2024	$28.08M	-33.9%
Dec 2023	$42.47M	+119.5%
Sep 2023	$19.35M	-52.0%
Jun 2023	$40.31M	+19.2%
Mar 2023	$33.81M	-26.6%
Dec 2022	$46.07M	-39.9%
Sep 2022	$76.68M	-6.5%
Jun 2022	$81.98M	+8.3%
Mar 2022	$75.71M	+24.8%
Dec 2021	$60.68M	+2.5%
Sep 2021	$59.18M	+0.3%
Jun 2021	$59.03M	+24.8%
Mar 2021	$47.28M	+58.5%
Dec 2020	$29.83M	+4.0%
Sep 2020	$28.67M	+10.2%
Jun 2020	$26.02M	+42.2%
Mar 2020	$18.30M	+53.2%
Dec 2019	$11.94M	-12.8%
Sep 2019	$13.70M	-29.3%
Jun 2019	$19.39M	+22.1%
Mar 2019	$15.88M	+28.5%
Dec 2018	$12.36M	-1.7%
Sep 2018	$12.57M	+38.5%
Jun 2018	$9.07M	-14.2%
Mar 2018	$10.58M	+585.6%
Dec 2017	$1.54M	-74.7%
Sep 2017	$6.09M	-14.4%
Jun 2017	$7.12M	-28.2%
Mar 2017	$9.92M	+88.7%
Dec 2016	$5.26M	-9.4%
Sep 2016	$5.80M	-25.7%
Jun 2016	$7.81M	+18.0%
Mar 2016	$6.62M	+45.7%
Dec 2015	$4.54M	-10.5%
Sep 2015	$5.07M	-22.2%
Jun 2015	$6.52M	+3.5%
Mar 2015	$6.30M	+105.9%
Dec 2014	$3.06M	-8.2%
Sep 2014	$3.34M	-18.4%
Jun 2014	$4.09M	-35.1%
Mar 2014	$6.30M	+3.7%
Dec 2013	$6.07M	-31.5%
Sep 2013	$8.87M	+29.9%
Jun 2013	$6.83M	+58.4%
Mar 2013	$4.31M	-41.2%
Dec 2012	$7.33M	+137.6%
Sep 2012	$3.08M	+40.8%
Jun 2012	$2.19M	+30.6%
Mar 2012	$1.68M	+182.1%
Mar 2011	-$2.04M	-368.0%
Dec 2010	$761.80K	-18.4%
Sep 2010	$933.70K	-27.7%
Jun 2010	$1.29M	+193.8%
Mar 2010	-$1.38M	-33.6%
Dec 2009	-$1.03M	-17.6%
Sep 2009	-$876.00K	+20.7%
Jun 2009	-$1.11M	+62.2%
Mar 2009	-$2.92M	-1,031.7%
Dec 2008	-$258.10K	-307.7%
Sep 2008	-$63.30K	-100.8%
Jun 2008	$8.20M	+325.5%
Mar 2008	-$3.64M	-359.5%
Dec 2007	-$791.40K	-198.9%
Sep 2007	$800.40K	+359.5%
Jun 2007	$174.20K	+188.4%
Mar 2007	-$197.00K	-58.2%
Dec 2006	-$124.50K	+87.1%
Sep 2006	-$968.50K	>-9,900.0%
Jun 2006	$3,900.00	+100.4%
Mar 2006	-$882.80K	-173.5%
Dec 2005	-$322.80K	+44.9%
Sep 2005	-$586.20K	-160.4%
Jun 2005	$970.50K	+313.7%
Mar 2005	-$454.20K	+50.0%

Month	Value	Change
Dec 2004	-$909.00K	+43.1%
Sep 2004	-$1.60M	-258.6%
Jun 2004	-$445.20K	+39.0%
Mar 2004	-$730.40K	+63.4%
Dec 2003	-$2.00M	+0.6%
Sep 2003	-$2.01M	-5.5%
Jun 2003	-$1.90M	-21.4%
Mar 2003	-$1.57M	-127.9%
Dec 2002	-$688.00K	+33.7%
Sep 2002	-$1.04M	-4.0%
Jun 2002	-$998.10K	+8.6%
Mar 2002	-$1.09M	-6.3%
Dec 2001	-$1.03M	+35.6%
Sep 2001	-$1.60M	+0.5%
Jun 2001	-$1.60M	+14.4%
Mar 2001	-$1.88M	+9.4%
Dec 2000	-$2.07M	-20.6%
Sep 2000	-$1.72M	-22.9%
Jun 2000	-$1.40M	-185.2%
Mar 2000	-$489.60K	+72.5%
Dec 1999	-$1.78M	-103.0%
Sep 1999	-$878.00K	-121.7%
Jun 1999	-$396.00K	+49.5%
Mar 1999	-$783.70K	-202.7%
Dec 1998	-$258.90K	-36.8%
Sep 1998	-$189.20K	+39.3%
Jun 1998	-$311.80K	+1.0%
Mar 1998	-$315.00K	>-9,900.0%
Dec 1997	$0.00	+100.0%
Sep 1997	-$300.00K	>-9,900.0%
Jun 1997	$0.00	-100.0%
Mar 1997	$400.00K	+500.0%
Dec 1996	-$100.00K	-133.3%
Sep 1996	$300.00K	+160.0%
Jun 1996	-$500.00K	+70.6%
Mar 1996	-$1.70M	+15.0%
Dec 1995	-$2.00M	-233.3%
Sep 1995	-$600.00K	+72.7%
Jun 1995	-$2.20M	-4.8%
Mar 1995	-$2.10M	+58.8%
Dec 1994	-$5.10M	+1.9%
Sep 1994	-$5.20M	0.0%
Jun 1994	-$5.20M	-36.8%
Mar 1994	-$3.80M	+20.8%
Dec 1993	-$4.80M	-17.1%
Sep 1993	-$4.10M	+8.9%
Jun 1993	-$4.50M	-4,600.0%
Mar 1993	$100.00K	+101.8%
Dec 1992	-$5.50M	-37.5%
Sep 1992	-$4.00M	-544.4%
Jun 1992	$900.00K	+325.0%
Mar 1992	-$400.00K	+94.8%
Dec 1991	-$7.70M	-305.3%
Sep 1991	-$1.90M	-58.3%
Jun 1991	-$1.20M	+69.2%
Mar 1991	-$3.90M	-225.0%
Dec 1990	-$1.20M	0.0%
Sep 1990	-$1.20M	-9.1%
Jun 1990	-$1.10M	+89.9%
Mar 1990	-$10.90M	-402.8%
Dec 1989	$3.60M	+33.3%
Sep 1989	$2.70M	+8.0%
Jun 1989	$2.50M	+125.8%
Mar 1989	-$9.70M	-459.3%
Dec 1988	$2.70M	+58.8%
Sep 1988	$1.70M	-5.6%
Jun 1988	$1.80M	+121.7%
Mar 1988	-$8.30M	-738.5%
Dec 1987	$1.30M	-23.5%
Sep 1987	$1.70M	-67.3%
Jun 1987	$5.20M	+170.3%
Mar 1987	-$7.40M	-840.0%
Dec 1986	$1.00M	+11.1%
Sep 1986	$900.00K	+28.6%
Jun 1986	$700.00K	+113.5%
Mar 1986	-$5.20M	-677.8%
Dec 1985	$900.00K	0.0%
Sep 1985	$900.00K	0.0%
Jun 1985	$900.00K	+123.7%
Mar 1985	-$3.80M	-733.3%
Dec 1984	$600.00K	0.0%
Sep 1984	$600.00K	0.0%
Jun 1984	$600.00K	-

FAQ

What is the current quarterly EBITDA of RGEN?: As of today, RGEN quarterly EBITDA is $32.08M
What is RGEN quarterly EBITDA most recent change?: RGEN quarterly EBITDA was down -27.31% on September 30, 2026
What is 1-year change in RGEN quarterly EBITDA?: RGEN quarterly EBITDA is down -34.64% year-over-year
How far is RGEN quarterly EBITDA from its all-time high?: RGEN quarterly EBITDA is currently -60.87% below its historical high of $81.98M set on June 30, 2022
How does RGEN quarterly EBITDA rank versus sector peers?: RGEN quarterly EBITDA is higher than 81.56% of companies in Healthcare sector
When is RGEN next earnings release?: The next earnings release for RGEN is on February 23, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$161.90M$17.00M-9.50%

September 30, 2026

Summary

Current Value: As of today, RGEN TTM EBITDA is $161.90M, down -9.50% on September 30, 2026
Historical Performance: RGEN TTM EBITDA is down -5.27% year-over-year, up +16.02% over the past 3 years
All-Time High Comparison: RGEN TTM EBITDA is currently -45.13% below its historical high of $295.06M set on September 30, 2022
3-Year Low Comparison: RGEN TTM EBITDA is +46.00% above its 3-year low of $110.89M reached on December 31, 2024
Sector Comparison: RGEN TTM EBITDA is higher than 84.25% of companies in Healthcare sector

Performance

RGEN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$161.90M	-9.5%	-5.3%	+16.0%	-17.1%
Annual EBITDA	Dec 31, 25	$138.32M	–	+26.7%	-45.3%	+27.7%
Quarterly EBITDA	Sep 30, 26	$32.08M	-27.3%	-34.6%	+65.8%	-45.8%
Price	Oct 30, 26	$176.94	+23.2%	+22.4%	+55.0%	-39.1%
PE Ratio	Oct 30, 26	-	–	–	–	–
TTM Revenue	Sep 30, 26	$805.61M	+2.6%	+13.8%	+23.5%	+35.9%
TTM EPS	Sep 30, 26	-$0.21	-128.6%	-912.4%	-111.9%	-110.0%
	Sep 30, 26	$69.11M	-2.6%	+47.9%	+8.5%	-56.9%
TTM Net Income	Sep 30, 26	-$11.80M	-128.4%	-779.2%	-111.7%	-109.9%

TTM EBITDA Highs

RGEN TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$178.90M	Jun 30, 26	-9.5%
3Y	$178.90M	Jun 30, 26	-9.5%
5Y	$295.06M	Sep 30, 22	-45.1%
All	$295.06M	Sep 30, 22	-45.1%

TTM EBITDA Lows

RGEN TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$161.90M	Sep 30, 26	at low
3Y	$110.89M	Dec 31, 24	+46.0%
5Y	$110.89M	Dec 31, 24	+46.0%
All	-$19.30M	Dec 31, 94	+938.9%

TTM EBITDA History

Month	Value	Change
Sep 2026	$161.90M	-9.5%
Jun 2026	$178.90M	+0.5%
Mar 2026	$177.95M	+0.4%
Dec 2025	$177.16M	+3.7%
Sep 2025	$170.91M	+23.0%
Jun 2025	$139.00M	+11.6%
Mar 2025	$124.55M	+12.3%
Dec 2024	$110.89M	-4.8%
Sep 2024	$116.46M	-1.8%
Jun 2024	$118.64M	-8.9%
Mar 2024	$130.21M	-4.2%
Dec 2023	$135.95M	-2.6%
Sep 2023	$139.54M	-29.1%
Jun 2023	$196.87M	-17.5%
Mar 2023	$238.54M	-14.9%
Dec 2022	$280.44M	-5.0%
Sep 2022	$295.06M	+6.3%
Jun 2022	$277.56M	+9.0%
Mar 2022	$254.60M	+12.6%
Dec 2021	$226.17M	+15.8%
Sep 2021	$195.32M	+18.5%
Jun 2021	$164.82M	+25.0%
Mar 2021	$131.80M	+28.2%
Dec 2020	$102.82M	+21.1%
Sep 2020	$84.93M	+21.4%
Jun 2020	$69.96M	+10.5%
Mar 2020	$63.34M	+4.0%
Dec 2019	$60.92M	-0.7%
Sep 2019	$61.34M	+1.9%
Jun 2019	$60.21M	+20.7%
Mar 2019	$49.89M	+11.9%
Dec 2018	$44.58M	+32.0%
Sep 2018	$33.77M	+23.7%
Jun 2018	$27.29M	+7.7%
Mar 2018	$25.33M	+2.7%
Dec 2017	$24.67M	-13.1%
Sep 2017	$28.38M	+1.0%
Jun 2017	$28.09M	-2.4%
Mar 2017	$28.79M	+12.9%
Dec 2016	$25.49M	+2.9%
Sep 2016	$24.77M	+3.0%
Jun 2016	$24.05M	+5.7%
Mar 2016	$22.76M	+1.4%
Dec 2015	$22.44M	+7.1%
Sep 2015	$20.96M	+9.0%
Jun 2015	$19.22M	+14.5%
Mar 2015	$16.78M	+0.0%
Dec 2014	$16.78M	-15.2%
Sep 2014	$19.79M	-21.8%
Jun 2014	$25.33M	-9.8%
Mar 2014	$28.07M	+7.6%
Dec 2013	$26.08M	-4.6%
Sep 2013	$27.33M	+26.8%
Jun 2013	$21.55M	+27.4%
Mar 2013	$16.91M	+18.4%
Dec 2012	$14.28M	+105.4%
Sep 2012	$6.95M	+79.7%
Jun 2012	$3.87M	+130.6%
Mar 2012	$1.68M	+77.6%
Mar 2011	$944.60K	-41.3%
Dec 2010	$1.61M	+985.1%
Sep 2010	-$181.90K	+90.9%
Jun 2010	-$1.99M	+54.6%
Mar 2010	-$4.39M	+26.0%
Dec 2009	-$5.93M	-15.0%
Sep 2009	-$5.16M	-18.7%
Jun 2009	-$4.35M	-187.7%
Mar 2009	$4.96M	+16.9%
Dec 2008	$4.24M	+14.4%
Sep 2008	$3.71M	-18.9%
Jun 2008	$4.57M	+232.4%
Mar 2008	-$3.45M	>-9,900.0%
Dec 2007	-$13.80K	-102.1%
Sep 2007	$653.10K	+158.5%
Jun 2007	-$1.12M	+13.2%
Mar 2007	-$1.29M	+34.8%
Dec 2006	-$1.97M	+9.1%
Sep 2006	-$2.17M	-21.4%
Jun 2006	-$1.79M	-117.7%
Mar 2006	-$821.30K	-109.1%
Dec 2005	-$392.70K	+59.9%
Sep 2005	-$978.90K	+50.8%
Jun 2005	-$1.99M	+41.6%
Mar 2005	-$3.41M	+7.5%

Month	Value	Change
Dec 2004	-$3.68M	+22.8%
Sep 2004	-$4.77M	+8.0%
Jun 2004	-$5.18M	+22.0%
Mar 2004	-$6.64M	+11.2%
Dec 2003	-$7.48M	-21.2%
Sep 2003	-$6.17M	-18.7%
Jun 2003	-$5.20M	-21.1%
Mar 2003	-$4.29M	-12.5%
Dec 2002	-$3.82M	+8.2%
Sep 2002	-$4.16M	+11.8%
Jun 2002	-$4.71M	+11.4%
Mar 2002	-$5.32M	+12.8%
Dec 2001	-$6.10M	+14.6%
Sep 2001	-$7.15M	+1.6%
Jun 2001	-$7.26M	-3.0%
Mar 2001	-$7.06M	-24.4%
Dec 2000	-$5.67M	-5.3%
Sep 2000	-$5.38M	-18.4%
Jun 2000	-$4.55M	-28.2%
Mar 2000	-$3.55M	+7.7%
Dec 1999	-$3.84M	-65.8%
Sep 1999	-$2.32M	-42.3%
Jun 1999	-$1.63M	-5.5%
Mar 1999	-$1.54M	-43.6%
Dec 1998	-$1.07M	-31.7%
Sep 1998	-$816.00K	+12.0%
Jun 1998	-$926.80K	-50.7%
Mar 1998	-$615.00K	-715.0%
Dec 1997	$100.00K	>+9,900.0%
Sep 1997	$0.00	-100.0%
Jun 1997	$600.00K	+500.0%
Mar 1997	$100.00K	+105.0%
Dec 1996	-$2.00M	+48.7%
Sep 1996	-$3.90M	+18.8%
Jun 1996	-$4.80M	+26.2%
Mar 1996	-$6.50M	+5.8%
Dec 1995	-$6.90M	+31.0%
Sep 1995	-$10.00M	+31.5%
Jun 1995	-$14.60M	+17.0%
Mar 1995	-$17.60M	+8.8%
Dec 1994	-$19.30M	-1.6%
Sep 1994	-$19.00M	-6.1%
Jun 1994	-$17.90M	-4.1%
Mar 1994	-$17.20M	-29.3%
Dec 1993	-$13.30M	+5.0%
Sep 1993	-$14.00M	-0.7%
Jun 1993	-$13.90M	-63.5%
Mar 1993	-$8.50M	+5.6%
Dec 1992	-$9.00M	+19.6%
Sep 1992	-$11.20M	-23.1%
Jun 1992	-$9.10M	+18.8%
Mar 1992	-$11.20M	+23.8%
Dec 1991	-$14.70M	-79.3%
Sep 1991	-$8.20M	-9.3%
Jun 1991	-$7.50M	-1.4%
Mar 1991	-$7.40M	+48.6%
Dec 1990	-$14.40M	-50.0%
Sep 1990	-$9.60M	-68.4%
Jun 1990	-$5.70M	-171.4%
Mar 1990	-$2.10M	-133.3%
Dec 1989	-$900.00K	+50.0%
Sep 1989	-$1.80M	+35.7%
Jun 1989	-$2.80M	+20.0%
Mar 1989	-$3.50M	-66.7%
Dec 1988	-$2.10M	+40.0%
Sep 1988	-$3.50M	0.0%
Jun 1988	-$3.50M	-3,400.0%
Mar 1988	-$100.00K	-112.5%
Dec 1987	$800.00K	+60.0%
Sep 1987	$500.00K	+266.7%
Jun 1987	-$300.00K	+93.8%
Mar 1987	-$4.80M	-84.6%
Dec 1986	-$2.60M	+3.7%
Sep 1986	-$2.70M	0.0%
Jun 1986	-$2.70M	-8.0%
Mar 1986	-$2.50M	-127.3%
Dec 1985	-$1.10M	+21.4%
Sep 1985	-$1.40M	+17.6%
Jun 1985	-$1.70M	+15.0%
Mar 1985	-$2.00M	-211.1%
Dec 1984	$1.80M	+50.0%
Sep 1984	$1.20M	+100.0%
Jun 1984	$600.00K	-

FAQ

What is the current TTM EBITDA of RGEN?: As of today, RGEN TTM EBITDA is $161.90M
What is RGEN TTM EBITDA most recent change?: RGEN TTM EBITDA was down -9.50% on September 30, 2026
What is 1-year change in RGEN TTM EBITDA?: RGEN TTM EBITDA is down -5.27% year-over-year
How far is RGEN TTM EBITDA from its all-time high?: RGEN TTM EBITDA is currently -45.13% below its historical high of $295.06M set on September 30, 2022
How does RGEN TTM EBITDA rank versus sector peers?: RGEN TTM EBITDA is higher than 84.25% of companies in Healthcare sector
When is RGEN next earnings release?: The next earnings release for RGEN is on February 23, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

RGEN Official Website www.repligen.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000119312526076528/0001193125-26-076528-index.htm
RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen